We use cookies on this site to enable your digital experience. By continuing to use this site, you are agreeing to our cookie policy. close

$28M Philly Xarelto Verdict Ripe For Reversal, Attys Say

Law360, Philadelphia (December 6, 2017, 6:27 PM EST) -- After three prior bellwether trial losses, plaintiffs in litigation over the anticoagulant Xarelto are hoping to gain momentum following a $27.8 million verdict in Philadelphia on Tuesday, but attorneys say the award faces an uncertain future thanks to testimony that additional warnings would not have changed a doctor's decision to prescribe the drug.

The verdict against a pair of Johnson & Johnson and Bayer AG units, which included $26 million in punitive damages, came despite testimony from plaintiff Lynn Hartman's physician that additional warnings about the...
To view the full article, register now.
Law360 Pro Say Podcast
Check out Law360's new podcast, Pro Say, which offers a weekly recap of both the biggest stories and hidden gems from the world of law.